Alexandria Real Estate Equities Reports Q2 2026 Financial Results with $73.7M Net Loss

Alexandria Real Estate Equities, Inc. (NYSE: ARE) reported its financial results for the second quarter of 2026, revealing a net loss attributable to common stockholders of $73.7 million, or $(0.43) per share, compared to a loss of $109.6 million, or $(0.64) per share, in the same period last year. Total revenues for the quarter decreased by 12.8% to $662.8 million, down from $762.0 million in the prior year, primarily driven by a decline in rental income and tenant recoveries. The company’s income from rentals fell to $643.2 million from $737.3 million, reflecting a decrease in occupancy rates, which dropped to 86.9% from 90.8% year-over-year.

In terms of operational metrics, Alexandria's same property net operating income (NOI) decreased by 10.6% for the quarter, with cash basis NOI down 8.6%. The decline in occupancy was attributed to key lease expirations and the impact of previously disclosed vacancies. The company reported that 97% of its leases contain annual rent escalations, which are expected to help stabilize future revenues. Alexandria's total assets as of June 30, 2026, stood at $34.6 billion, an increase from $34.1 billion at the end of 2025, driven by investments in real estate totaling $29.1 billion.

Strategically, Alexandria has been focusing on its Megacampus ecosystems, which are designed to attract high-quality tenants in the life sciences sector. The company has a robust development pipeline, with 2.8 million square feet of Class A/A+ properties under construction. Alexandria expects to generate an incremental annual net operating income of $57 million from projects placed into service in the first half of 2026, with an additional $42 million anticipated from projects expected to stabilize in the second half of the year.

Financially, Alexandria has maintained a strong balance sheet with significant liquidity of $3.6 billion as of June 30, 2026. The company has extended its unsecured senior line of credit to 2032 and has a well-laddered debt maturity schedule, with only 6% of its total debt maturing through 2028. Alexandria's net debt and preferred stock to Adjusted EBITDA ratio was reported at 7.0x, with a fixed-charge coverage ratio of 3.3x for the quarter. The company plans to fund a significant portion of its capital requirements through real estate dispositions, sales of partial interests, and other capital sources, with a target of approximately $2.9 billion for the year.

Looking ahead, Alexandria anticipates continued challenges in the life sciences real estate market due to increased supply and moderated demand. The company is actively evaluating its development projects and may pivot some to lower-cost advanced technology uses. Despite these challenges, Alexandria remains committed to its strategic focus on high-quality, collaborative environments that support innovation and growth in the life sciences sector.